ADHD drugs lacking in safety studies, Boston researchers find

RESEARCHERS: ADHD DRUGS LACKING IN SAFETY STUDIES

Nearly 1 in 9 children have been diagnosed with attention deficit hyperactivity disorder, but drugs they take to treat symptoms — which include methylphenidate (Ritalin) and amphetamine/dextroamphetamine (Adderall) — have not been investigated in drug clinical trials to determine whether they’re safe to take long term, according to a new study by Boston Children’s Hospital researchers. The study’s authors emphasized that this doesn’t mean ADHD drugs pose safety risks but that the initial approval trials — which made the drugs available to thousands of children for long-term use — largely ignored the possibility of safety issues

Read More